Pay in 4 interest-free payments of $40.62 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
Upregulation of PD-L1 on immune cells (especially myeloid cells) can also lead to formation of an immunosuppressive environment in a highly localized manner that also allow the cancer cells to proliferate
Cells must have the ability to secrete matrix metalloproteinases (MMPs) in order to undergo cell invasion
The depth of color reaction was positively correlated with the concentration of IFN-γ in the sample
the cells are inoculated
IL-19 promotes the Th2 (regulatory) T-cell response which supports an anti-inflammatory lymphocyte phenotype
Anti-PD-1 Monoclonal Antibody (Pembrolizumab) Size:5mg Upregulation of PD-L1 on immuneProduct Specification Host Human Antigen PD 1 Antibody Type Recombinant mAb Isotype IgG4,k Application Blocking of PD 1 PD L1 signaling Functional assays Reactivity Hu Purification Protein A Concentration 5 mg ml Conjugation Unconjugated Physical Appearance Liquid Storage Buffer PBS pH7. 4, containing no preservative. Endotoxin level is 1 EU mg Stability & Storage 12 months from date of receipt reconstitution, 2 to 8 C as supplied Background